Safety and Efficacy of Ambrisentan–Phosphodiesterase Type 5 (PDE5) Inhibitor Combination Therapy for Japanese Pulmonary Arterial Hypertension Patients in Real-World Clinical Practice

Background: This retrospective study was conducted to evaluate the safety and efficacy of ambrisentan combination therapy with phosphodiesterase type 5 (PDE5) inhibitors in Japanese patients with pulmonary arterial hypertension (PAH). Methods and Results: PAH patients who received ambrisentan for th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Circ Rep
Main Authors: Kataoka, Masaharu, Satoh, Toru, Matsubara, Hiromi, Yamamoto, Koji, Inada, Tsukasa, Umezawa, Kazunari, Takahashi, Tomohiko, Nakano, Atsushi, Fukuda, Keiichi
Formato: Artigo
Idioma:Inglês
Publicado em: The Japanese Circulation Society 2019
Assuntos:
Original article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7889478/
https://ncbi.nlm.nih.gov/pubmed/33693149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1253/circrep.CR-19-0029
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados